Results 1 to 10 of about 6,306 (210)

Metaheuristics for pharmacometrics [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
Metaheuristics is a powerful optimization tool that is increasingly used across disciplines to tackle general purpose optimization problems. Nature‐inspired metaheuristic algorithms is a subclass of metaheuristic algorithms and have been shown to be ...
Seongho Kim   +4 more
doaj   +5 more sources

Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations

open access: yesPharmaceutics, 2022
Pharmacometrics is a multidisciplinary field utilizing mathematical models of physiology, pharmacology, and disease to describe and quantify the interactions between medication and patient.
Frank Bennis   +2 more
exaly   +3 more sources

Pharmacometrics in tuberculosis: progress and opportunities [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2022
Tuberculosis (TB) remains one of the leading causes of death by a communicable agent, infecting up to one-quarter of the world's population, predominantly in disadvantaged communities. Pharmacometrics employ quantitative mathematical models to describe the relationships between pharmacokinetics and pharmacodynamics, and to predict drug doses, exposures
Elin Svensson   +2 more
exaly   +4 more sources

AI for NONMEM Coding in Pharmacometrics Research and Education: Shortcut or Pitfall? [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Artificial intelligence (AI) is increasingly being explored as a tool to support pharmacometric modeling, particularly in addressing the coding challenges associated with NONMEM.
Wenhao Zheng   +5 more
doaj   +2 more sources

Pharmacometrics in the Age of Large Language Models: A Vision of the Future

open access: yesPharmaceutics
Background: Large Language Models (LLMs) have driven significant advances in artificial intelligence (AI), with transformative applications across numerous scientific fields, including biomedical research and drug development.
Paolo Magni   +2 more
exaly   +3 more sources

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference. [PDF]

open access: yesClin Pharmacol Ther
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Adeagbo BA   +12 more
europepmc   +3 more sources

The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases

open access: yesPharmaceutics
Autoimmune diseases (AIDs) are a group of disorders in which the immune system attacks the body’s own tissues, leading to chronic inflammation and organ damage.
Artur Świerczek   +2 more
exaly   +3 more sources

Advancing pharmacometrics in Africa—Transition from capacity development toward job creation

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Trained pharmacometricians remain scarce in Africa due to limited training opportunities, lack of a pharmaceutical product development ecosystem, and emigration to high‐income countries.
Goonaseelan (Colin) Pillai   +10 more
doaj   +2 more sources

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice [PDF]

open access: yesArhiv za farmaciju, 2021
Due to frequent clinical trial failures and consequently fewer new drug approvals, the need for improvement in drug development has, to a certain extent, been met using model-based drug development.
Roganović Maša   +6 more
doaj   +1 more source

Regulatory utility of pharmacometrics in the development and evaluation of antimicrobial agents and its recent progress in China

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
Pharmacometrics is an emerging science that interprets drug, disease, and trial information in a mathematical fashion to inform and facilitate efficient drug development and/or regulatory decisions.
Ming Zhao   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy